Tenderwize
Retour à la recherche

Delivery of Medicinal Products for the Needs of SBALHZ EAD

СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ НА ХЕМАТОЛОГИЧНИ ЗАБОЛЯВАНИЯ ЕАД·гр. София, Bulgaria·BGN 42.5M·Deadline Jun 07, 2027 · 283 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на СБАЛХЗ ЕАД

75/100

Score d'opportunité

PromisingMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

75 / 100

Complexité

50 / 100

Facteurs de risque

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • BGN 42.5M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 24 MONTH
  • Supply of pharmaceutical products for a hematology hospital
  • Dynamic Purchasing System (DPS) with possible additions/changes to product list
Afficher le résumé complet

This tender is a Dynamic Purchasing System (DPS) for the supply of various pharmaceutical products to the Specialized Hospital for Active Treatment of Hematological Diseases (SBALHZ EAD) in Sofia, Bulgaria. The DPS has a duration of 24 months with a total estimated value of 42,451,813.04 BGN. The procedure is restricted and divided into one lot. Award is based on the lowest price per nomenclature item. Participation requires valid licenses for pharmaceutical production or wholesale, and a narcotic drugs license if applicable. The DPS is open for applications until 7 June 2027. Note: There is an inconsistency regarding EU funding; structured data indicates EU-funded, but the XML notice states no EU funds.

Risques

Participants must hold valid authorizations for pharmaceutical production/wholesale and narcotic drugs license if appli...

The DPS specification can be amended during the period, potentially adding new products or changing quantities, affecti...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Must hold valid authorization for manufacture or wholesale of medicinal products (or equivalent for EU/EEA)

Eligibility

  • Declaration of eligibility via ESPD (European Single Procurement Document) in Part IV A

Certifications

  • Must hold narcotic drugs license if offering such products

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Lowest price per nomenclature item.

Acheteur

Localisation

гр. София, BGR

Profil acheteur

Ouvrir le profil

Identifiant

200105779

Activité

Health

Lots (1)

LOT-0001

Delivery of Medicinal Products for the Needs of SBALHZ EAD

Supply of various medicinal products as detailed in the technical specification (International Nonproprietary Names, active substance quantity, pharmaceutical form, estimated quantities, and estimated values). The specification may be partially amended during the DPS by adding new products or changing quantities.

SuppliesDPSEU fundedElectronic submission

BGN 42.5M

Valeur estimée

Localisation

София, Bulgaria

Durée

Jun 2025

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jun 07, 2027

Détails de la procédure

Date de publication
04 Jun 2025
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
363187-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30